HPV E6 Covalent Inhibitor Market Benefits from Breakthroughs in...

agregó una foto Home

2026-07-27 05:25:27 -

HPV E6 Covalent Inhibitor Market Benefits from Breakthroughs in Covalent Small-Molecule Drug Design

The global HPV E6 Covalent Inhibitor Market is projected to grow from USD 1.2 billion in 2026 to USD 3.3 billion by 2036, expanding at a 10.6% CAGR during the forecast period. Reaching USD 1.1 billion in 2025, market growth is being fueled by expanding investments in viral-oncoprotein research, precision oncology frameworks, and novel targeted therapies...

0 Commentarios 0 Acciones 88 Views 0 Vista previa